Razelle Kurzrock: 4 ways to approach tumors with undruggable fusions
Razelle Kurzrock shared a post on X:
“4 ways to approach tumors with undruggable fusions.
1. Look at RNA expression.
2. Look at immunomics for immunotherapy.
3. Look at IHCs and consider an ADC or other matched therapy.
4. Functional assays.”
Source: Razelle Kurzrock/X
Dr. Razelle Kurzrock is the Chief Medical Officer at ACT Genomics, Senior Deputy Director at the HKSH Cancer Centre, and Senior Advisor at CureScience. She is also a Professor of Medicine at the University of California, San Diego (UCSD) and the Director of the Center for Personalized Cancer Therapy at UCSD. Additionally, Dr. Kurzrock is the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center.
Renowned as one of the world’s top 25 voices in precision medicine, she is celebrated for her contributions, of having over 950 scientific and medical publications. Dr. Kurzrock’s work continues to shape the landscape of oncology, driving innovation and breakthroughs in cancer treatment and research.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023